Karen Deborah Chagin - 09 Jun 2025 Form 4 Insider Report for Context Therapeutics Inc. (CNTX)

Role: Chief Medical Officer
Signature: /s/ Alex Levit, Attorney-in-Fact
Issuer symbol: CNTX
Transactions as of: 09 Jun 2025
Net transactions value: $0
Form type: 4
Filing time: 09 Jun 2025, 17:22:17 UTC
Next filing: 23 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Chagin Karen Deborah	Chief Medical Officer	2001 MARKET ST, SUITE 3915 UNIT #15, PHILADELPHIA	/s/ Alex Levit, Attorney-in-Fact	09 Jun 2025	0002070710

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CNTX	Stock Option (right to buy)	Award	$0	+153,000		$0.000000	153,000	09 Jun 2025	Common Stock	153,000	$0.7030	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on June 9, 2026, and the balance vests in equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer.